Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in

Status Not yet recruiting

Clinical Trial Summary

This is a prospective multi-center interventional study that will be performed in an effort to assess the diagnostic accuracy performance of preoperative vaginal ultrasound-guided biopsy (VUGB) to detect the exact histology of uterine tumors and thereafter triage cases being eligible for morcellation during laparoscopic resection. Ten tertiary French centers will participate in the present study.

Clinical Trial Description

Prior to carrying out the research, the informed consent of the person must be obtained after being informed of the purpose of the research, its conduct and duration, benefits, potential risks and constraints of the study.

During the inclusion check-up, exams must be performed within 30 days before the guided echo biopsy: clinical examination, gynecological examination, pain assessment (visual or verbal scale), biological and radiological assessment (Doppler ultrasound Pelvis and MRI pelvis).

The echo-guided biopsy will be performed by a specialized radiologist by transvaginal and exclusive transuterine approach. Local anesthesia will be performed. A pain assessment will be performed during the biopsy (visual or verbal scale).

Between the biopsy and the procedure, the patient will be reviewed by the investigating surgeon to check the outcome of the biopsy, any pain or complications of the biopsy.

The surgical procedure will be performed by laparotomy and will consist of an extra-facial hysterectomy without fragmentation of the surgical specimen (extraction technique "in block"). During the procedure, the investigating surgeon will perform a description of the abdominal and pelvic cavity and perform a block excision of the tumor.

At one month of the surgery, patient will be reviewed by the investigating surgeon for a postoperative visit with clinical examination, gynecological and histopathological results.

Thereafter, the follow-up of the patients will be carried out according to the standards of care according to the histopathological results. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04250766
Study type	Interventional
Source	Institut Bergonié
Contact	Frédéric GUYON, MD
Phone	05.56.33.78.30
Email	f.guyon@bordeaux.unicancer.fr
Status	Not yet recruiting
Phase	N/A
Start date	June 2020
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05741671` - Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Recruiting	`NCT04145518` - Mechanistic Characterization of Uterine Pain	Phase 4
Completed	`NCT05419414` - The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis	N/A
Recruiting	`NCT04272086` - Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy	Phase 4
Completed	`NCT00156156` - Study of Asoprisnil in the Treatment of Uterine Fibroids.	Phase 3
Recruiting	`NCT06269809` - Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial	N/A
Recruiting	`NCT06429163` - Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy	N/A
Recruiting	`NCT04295109` - Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function	N/A
Terminated	`NCT02879058` - Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients	N/A
Recruiting	`NCT04311073` - Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies	Phase 3
Recruiting	`NCT06143631` - Prescription of Letrozole for Uterine Myoma	Phase 4
Completed	`NCT03927651` - ICG to Assess Ovarian Perfusion	Early Phase 1
Recruiting	`NCT03550703` - Open Label Immunotherapy of Myoma	Phase 2
Completed	`NCT00910468` - Robot-Assisted Laparoscopic Myomectomy Is an Improvement Over Laparotomy in Patients With a Limited Number of Fibroids	N/A
Recruiting	`NCT05518812` - Carboprost (Hemabate) for Fibroid Resection	Early Phase 1
Recruiting	`NCT03757975` - Impact of Hysterectomy on Quality of Life and Urethral Length
Active, not recruiting	`NCT04434066` - Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy	N/A
Recruiting	`NCT05017246` - Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy	Phase 2
Completed	`NCT05643339` - The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler Outcomes

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR) — BIOPSAR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms